The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
Obesity, Type 2 Diabetes, and Cancer Risk
Open accessAbstract
Obesity and type 2 diabetes have both been associated with increased cancer risk and are becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and dyslipidemia are associated with both obesity and type 2 diabetes and have been implicated in the obesity-cancer relationship. Multiple mechanisms have been proposed to link obesity and diabetes with cancer progression, including an increase in insulin/IGF-1 signaling, lipid and glucose uptake and metabolism, alterations in the profile of cytokines, chemokines, and adipokines, as well as changes in the adipose tissue directly adjacent to the cancer sites. This review aims to summarize and provide an update on the epidemiological and mechanistic evidence linking obesity and type 2 diabetes with cancer, focusing on the roles of insulin, lipids, and adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–324 of 324
Pang, Y., Kartsonaki, C., Guo, Y., Bragg, F., Yang, L., Bian, Z., Chen, Y., Iona, A., Millwood, I. Y., Lv, J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30599 · Cited by 108
Menopause is a determinant of breast adipose inflammation
Iyengar, N. M., Morris, P. G., Zhou, X. K., Gucalp, A., Giri, D., Harbus, M. D., Falcone, D. J., Krasne, M. D., Vahdat, L. T., Subbaramaiah, K., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0243 · Cited by 106
DuSell, C. D., Nelson, E. R., Wang, X., Abdo, J., Mödder, U. I., Umetani, M., Gesty‐Palmer, D., Javitt, N. B., Khosla, S., & McDonnell, D. P. (2010) · Endocrinology · doi:10.1210/en.2010-0080 · Cited by 106
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study
Jamnagerwalla, J., Howard, L. E., Allott, E. H., Vidal, A. C., Moreira, D. M., Castro‐Santamaria, R., Andriole, G. L., Freeman, M. R., & Freedland, S. J. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-017-0030-9 · Cited by 106
Li, C., Li, Y., Zhang, D., & Jiang, W. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.04.009 · Cited by 104
Vaysse, C., Lømo, J., Garred, Ø., Fjeldheim, F., Lofterød, T., Schlichting, E., McTiernan, A., Frydenberg, H., Husøy, A., Lundgren, S., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0015-9 · Cited by 102
Causes of death in patients with familial hypercholesterolemia
Mabuchi, H., Miyamoto, S., Ueda, K., Oota, M., Takegoshi, T., WAKASUGI, T., & Takeda, R. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90107-3 · Cited by 101
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer
Kimbung, S., Chang, C., Bendahl, P., Dubois, L. G., Thompson, J. W., McDonnell, D. P., & Borgquist, S. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0533 · Cited by 100
Springer, N. L., Iyengar, N. M., Bareja, R., Verma, A., Jochelson, M. S., Giri, D. D., Zhou, X. K., Elemento, O., Dannenberg, A. J., & Fischbach, C. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.06.005 · Cited by 100
Brown, K. A., Iyengar, N. M., Zhou, X. K., Gucalp, A., Subbaramaiah, K., Wang, H., Giri, D. D., Morrow, M., Falcone, D. J., Wendel, N. K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3606 · Cited by 99
Ferguson, R. D., Novosyadlyy, R., Fierz, Y., Alikhani, N., Sun, H., Yakar, S., & LeRoith, D. (2012) · Breast Cancer Research · doi:10.1186/bcr3089 · Cited by 99
Self-citationUptake of a Cholesterol-Rich Emulsion by Breast Cancer
Graziani, S. R., Igreja, F., Hegg, R., Meneghetti, C., Brandizzi, L. I., Barboza, R., Amâncio, R. F., Pinotti, J. A., & Maranhão, R. C. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6654 · Cited by 98
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer
Mulligan, A. M., O’Malley, F. P., Ennis, M., Fantus, I. G., & Goodwin, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9471-x · Cited by 96
Murphy, N., Cross, A. J., Abubakar, M., Jenab, M., Aleksandrova, K., Boutron‐Ruault, M., Dossus, L., Racine, A., Kuhn, T. E., Katzke, V. A., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1001988 · Cited by 95
Cellular and physiological effects of C-peptide
Hills, C. E., & Brunskill, N. J. (2009) · Clinical Science · doi:10.1042/cs20080441 · Cited by 94
Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome
Link, A., Ayadhi, T., Böhm, M., & Nickenig, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl277 · Cited by 94
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 93
Self-citationOxysterols in human circulation: which role do they have?
Björkhem, I., Meaney, S., & Diczfalusy, U. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00003 · Cited by 91
Crowe, F. L., Key, T. J., Allen, N. E., Appleby, P. N., Overvad, K., Grønbæk, H., Tjønneland, A. M., Halkjær, J., Dossus, L., Boeing, H., et al. (2010) · Annals of Human Biology · doi:10.3109/03014460.2010.507221 · Cited by 91
The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
Murtola, T. J., Syvälä, H., Pennanen, P. T., Bläuer, M., Solakivi, T., Ylikomi, T. J., & Tammela, T. L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039445 · Cited by 90
Gallagher, E. J., Fierz, Y., Vijayakumar, A., Haddad, N., Yakar, S., & LeRoith, D. (2011) · Oncogene · doi:10.1038/onc.2011.495 · Cited by 90
Self-citationNagle, A. M., Levine, K. M., Tasdemir, N., Scott, J. A., Burlbaugh, K., Kehm, J., Katz, T. A., Boone, D. N., Jacobsen, B. M., Atkinson, J. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0279 · Cited by 89
Piirtola, M., Jelenkovic, A., Latvala, A., Sund, R., Honda, C., Inui, F., Watanabe, M., Tomizawa, R., Iwatani, Y., Ordoñana, J. R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200140 · Cited by 89
Accelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation
Núñez, N. P., Oh, W., Rozenberg, J. M., Perella, C., Anver, M. R., Barrett, J. C., Perkins, S. L., Berrigan, D. A., Moitra, J., Varticovski, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4102 · Cited by 88
Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
Wulaningsih, W., Garmo, H., Holmberg, L., Hammar, N., Jungner, I., Walldius, G., & Hemelrijck, M. V. (2012) · Journal of Cancer Epidemiology · doi:10.1155/2012/792034 · Cited by 88
Reggiani, F., Labanca, V., Mancuso, P., Rabascio, C., Talarico, G., Orecchioni, S., Manconi, A., & Bertolini, F. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0914 · Cited by 88
Cholesterol esters as growth regulators of lymphocytic leukaemia cells
Mulas, M. F., Abete, C., Pulisci, D., Pani, A., Massidda, B., Dessı̀, S., & Mandas, A. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00758.x · Cited by 87
The association between diabetes and breast cancer stage at diagnosis: a population-based study
Lipscombe, L. L., Fischer, H. D., Austin, P. C., Fu, L., Jaakkimainen, R. L., Ginsburg, O., Rochon, P. A., Narod, S. A., & Paszat, L. F. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3323-5 · Cited by 87
Periprostatic adipose inflammation is associated with high-grade prostate cancer
Gucalp, A., Iyengar, N. M., Zhou, X. K., Giri, D. D., Falcone, D. J., Wang, H., Williams, S. K., Krasne, M. D., Yaghnam, I., Kunzel, B., et al. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2017.31 · Cited by 85
Su, F., Ahn, S., Saha, A., DiGiovanni, J., & Kolonin, M. G. (2018) · Oncogene · doi:10.1038/s41388-018-0558-8 · Cited by 84
Predictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans
Lalia, A. Z., Dasari, S., Johnson, M. L., Robinson, M. M., Konopka, A. R., Distelmaier, K., Port, J. D., Glavin, M., Esponda, R. R., Nair, K. S., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2892 · Cited by 82
Leptin Signaling Mediates Obesity-Associated CSC Enrichment and EMT in Preclinical TNBC Models
Bowers, L. W., Rossi, E. L., McDonell, S. B., Doerstling, S. S., Khatib, S. A., Lineberger, C. G., Albright, J., Tang, X., deGraffenried, L. A., & Hursting, S. D. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0508 · Cited by 82
Mantuano, N. R., Stanczak, M. A., Oliveira, I. D. A., Kirchhammer, N., Filardy, A. A., Monaco, G., Santos, R. C., Fonseca, A. C., Fontes, M., Bastos, C. D. S., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0904 · Cited by 82
Mechanistic Links between Obesity, Insulin, and Cancer
Perry, R. J., & Shulman, G. I. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.12.003 · Cited by 81
Circulation of Progenitor Cells in Obese and Lean Colorectal Cancer Patients
Bellows, C. F., Zhang, Y., Chen, J., Frazier, M. L., & Kolonin, M. G. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0556 · Cited by 80
The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis
Tian, Y., Wang, K., Li, J., Wang, J., Wang, Z., Fan, Y., Ye, Y., Ji, G., & Li, Y. (2015) · Public Health Nutrition · doi:10.1017/s1368980015000646 · Cited by 80
Diabetes and Breast Cancer Subtypes
Bronsveld, H. K., Jensen, V., Vahl, P., Bruin, M. L. D., Cornelissen, S., Sanders, J., Auvinen, A. P., Haukka, J. K., Andersen, M. T., Vestergaard, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170084 · Cited by 79
Mass spectrometric detection of 27-hydroxycholesterol in breast cancer exosomes
Røberg‐Larsen, H., Lund, K., Seterdal, K. E., Solheim, S., Vehus, T. S., Solberg, N. T., Krauss, S. J. K., Lundanes, E., & Wilson, S. R. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.006 · Cited by 77
Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis
Yoon, Y. S., Keum, N., Zhang, X., Cho, E., & Giovannucci, E. L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.013 · Cited by 73
Carter, J. M., Hoskin, T. L., Pena, M.-C., Brahmbhatt, R. A., Winham, S. J., Frost, M. H., Stallings‐Mann, M. L., Radisky, D. C., Knutson, K. L., Visscher, D. W., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0245 · Cited by 73
Faria, S. S., Corrêa, L. H., Cardoso, G. S. H. R., de Sant’Ana, L. P., Almeida, R. D. N., & Magalhães, K. G. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e35 · Cited by 73
Highly specific role of the insulin receptor in breast cancer progression
Rostoker, R., Abelson, S., Bitton-Worms, K., Genkin, I., Ben-Shmuel, S., Dakwar, M., Orr, Z. S., Caspi, A., Tzukerman, M., & LeRoith, D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0490 · Cited by 72
Self-citationShen, Z., Zhu, D., Liu, J., Chen, J., Liu, Y., Hu, C., Li, Z., & Li, Y. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.02.001 · Cited by 71
Human endotrophin as a driver of malignant tumor growth
Bu, D., Crewe, C., Kusminski, C. M., Gordillo, R., Ghaben, A. L., Kim, M., Park, J., Deng, H., Xiong, W., Liu, X., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125094 · Cited by 71
Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study
Peila, R., & Rohan, T. E. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1623 · Cited by 70
Metabolic syndrome and risk of pancreatic cancer: A population‐based prospective cohort study
Xia, B., He, Q., Pan, Y., Gao, F., Liu, A., Tang, Y., Chong, C. C. N., Teoh, A. Y., Li, F., He, Y., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33172 · Cited by 70
Krycer, J. R., Phan, L., & Brown, A. J. (2012) · Biochemical Journal · doi:10.1042/bj20120545 · Cited by 69
Zhu, D., Shen, Z., Liu, J., Chen, J., Liu, Y., Hu, C., Li, Z., & Li, Y. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.006 · Cited by 69
Gallagher, E. J., Alikhani, N., Tobin‐Hess, A., Blank, J., Buffin, N. J., Zelenko, Z., Tennagels, N., Ulrich, W., & LeRoith, D. (2013) · Diabetes · doi:10.2337/db13-0249 · Cited by 68
Self-citationLiu, J., Xu, A., Lam, K. S. L., Wong, N.-S., Chen, J., Shepherd, P. R., & Wang, Y. (2013) · Oncotarget · doi:10.18632/oncotarget.1364 · Cited by 68
Iron, Lipids, and Risk of Cancer in the Framingham Offspring Cohort
Mainous, A. G., Wells, B. J., Koopman, R. J., Everett, C. J., & Gill, J. M. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi131 · Cited by 68
Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence
Slawinski, C., Barriuso, J., Guo, H., & Renehan, A. G. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.05.004 · Cited by 68
Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells
Badana, A. K., Chintala, M., Varikuti, G., Pudi, N., Kumari, S., Kappala, V. R., & Malla, R. R. (2016) · Journal of Breast Cancer · doi:10.4048/jbc.2016.19.4.372 · Cited by 66
Gordon, J. A., Noble, J. W., Midha, A., Derakhshan, F. N., Wang, G., Adomat, H. H., Guns, E. S. T., Lin, Y., Ren, S., Collins, C. C., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2529 · Cited by 66
Association between cholesterol intake and pancreatic cancer risk: Evidence from a meta-analysis
Chen, H., Qin, S., Wang, M., Zhang, T., & Zhang, S. (2015) · Scientific Reports · doi:10.1038/srep08243 · Cited by 65
Mao, Y., Tao, M., Jia, X., Xu, H. W., Chen, K., Tang, H., & Li, D. (2015) · Scientific Reports · doi:10.1038/srep17102 · Cited by 65
Hyperglycemia Impairs Neutrophil Mobilization Leading to Enhanced Metastatic Seeding
Fainsod-Levi, T., Gershkovitz, M., Völs, S., Kumar, S., Khawaled, S., Sagiv, J. Y., Sionov, R. V., Grunewald, M., Keshet, E., & Granot, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.010 · Cited by 64
Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort
Lu, D., Cornet, C. L., Sookthai, D., Johnson, T., Kaaks, R., & Fortner, R. T. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy115 · Cited by 64
Insulin and IGF-I Inhibit GH Synthesis and Release in Vitro and in Vivo by Separate Mechanisms
Gahete, M. D., Córdoba‐Chacón, J., Lin, Q., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1261 · Cited by 63
27-Hydroxycholesterol induces the transition of MCF7 cells into a mesenchymal phenotype
Sierralta, W. (2011) · Oncology Reports · doi:10.3892/or.2011.1284 · Cited by 62
Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index
Pollack, R. M., Ashash, A., Cahn, A., Rottenberg, Y., Stern, H., & Dresner–Pollak, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa458 · Cited by 62
Raza, S., Ohm, J. E., Dhasarathy, A., Schommer, J., Roche, C., Hammer, K. D. P., & Ghribi, O. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2551-7 · Cited by 61
Rentsch, C. T., Farmer, R. E., Eastwood, S. V., Mathur, R., Garfield, V., Farmaki, A., Bhaskaran, K., Chaturvedi, N., & Smeeth, L. L. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001600 · Cited by 61
Insulin resistance contributes to racial disparities in breast cancer prognosis in US women
Gallagher, E. J., Fei, K., Feldman, S. M., Port, E. R., Friedman, N. B., Boolbol, S. K., Killelea, B. K., Pilewskie, M. L., Choi, L., King, T. A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01281-y · Cited by 60
Self-citationWang, Y., Nasiri, A. R., Damsky, W., Perry, C. J., Zhang, X., Rabin-Court, A., Pollak, M., Shulman, G. I., & Perry, R. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.008 · Cited by 57
Murphy, K. A., James, B. R., Sjaastad, F. V., Kucaba, T. A., Kim, H., Brincks, E. L., Chua, S. C., Wilber, A. C., & Griffith, T. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701738 · Cited by 56
Dambal, S., Alfaqih, M. A., Sanders, S. E., Maravilla, E. J., Ramírez‐Torres, A., Galván, G. C., Reis-Sobreiro, M., Rotinen, M., Driver, L. M., Behrove, M. S., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0974 · Cited by 56
Wang, J., Li, C., Tao, H., Cheng, Y., Han, L., Li, X., & Hu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077950 · Cited by 54
Yeung, S. L. A., & Schooling, C. M. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000872 · Cited by 54
The Metabolic Syndrome and Risk of Prostate Cancer in Italy
Pelucchi, C., Serraino, D., Negri, E., Montella, M., Dellanoce, C., Talamini, R., & Vecchia, C. L. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.07.007 · Cited by 53
Shi, S., Lee, E.-J., Lin, Y., Chen, L., Zheng, H., He, X., Peng, J., Noonepalle, S. K. R., Shull, A. Y., Pei, F. C., et al. (2019) · PubMed · Cited by 53
Bowers, L. W., Brenner, A. J., Hursting, S. D., TEKMAL, R. R., & deGraffenried, L. A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3223-0 · Cited by 51
Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer
Ferguson, R. D., Gallagher, E. J., Cohen, D., Tobin‐Hess, A., Alikhani, N., Novosyadlyy, R., Haddad, N., Yakar, S., & LeRoith, D. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0333 · Cited by 51
Self-citationRaza, S., Meyer, M., Goodyear, C., Hammer, K. D. P., Guo, B., & Ghribi, O. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0422-x · Cited by 49
27-hydroxycholesterol decreases cell proliferation in colon cancer cell lines
Warns, J. A., Marwarha, G., Freking, N., & Ghribi, O. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.006 · Cited by 49
Obr, A. E., Kumar, S., Chang, Y., Bulatowicz, J. J., Barnes, B. J., Birge, R. B., Lazzarino, D. A., Gallagher, E. J., LeRoith, D., & Wood, T. L. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1063-2 · Cited by 49
Self-citationPan, K., Nelson, R. A., Wactawski‐Wende, J., Lee, D. J., Manson, J. E., Aragaki, A. K., Mortimer, J. E., Phillips, L. S., Rohan, T. E., Ho, G. Y. F., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz069 · Cited by 49
Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI
Dibaba, D. T., Braithwaite, D., & Akinyemiju, T. (2018) · Cancers · doi:10.3390/cancers10090299 · Cited by 48
27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling
DuSell, C. D., & McDonnell, D. P. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.003 · Cited by 47
The impact of 27-hydroxycholesterol on endometrial cancer proliferation
Gibson, D. A., Collins, F., Cousins, F. L., Esnal‐Zufiaurre, A., & Saunders, P. T. K. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0449 · Cited by 45
Jiao, K., Zhen, J., Wu, M., Teng, M., Yang, K., Zhou, Q., Hu, C., Zhou, M., Li, Y., & Li, Z. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0262 · Cited by 45
IGF1R Inhibition in Mammary Epithelia Promotes Canonical Wnt Signaling and Wnt1-Driven Tumors
Rota, L. M., Albanito, L., Shin, M. E., Goyeneche, C., Сакенович, Ш. С., Gallagher, E. J., LeRoith, D., Lazzarino, D. A., & Wood, T. L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0970 · Cited by 44
Self-citationThe temporal relationship between diabetes and cancer: A population‐based study
Lega, I. C., Wilton, A. S., Austin, P. C., Fischer, H. D., Johnson, J. A., & Lipscombe, L. L. (2016) · Cancer · doi:10.1002/cncr.30095 · Cited by 44
Hiramitsu, S., Ishikawa, T., Lee, W.-R., Khan, T., Crumbley, C., Khwaja, N., Zamanian, F., Asghari, A., Şen, M., Zhang, Y., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00470 · Cited by 43
Guo, F., Hong, W., Yang, M., Xu, D., Bai, Q., Li, X., & Chen, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.058 · Cited by 43
Onitilo, A. A., Stankowski, R. V., Berg, R. L., Engel, J. M., Glurich, I., Williams, G. M., & Doi, S. A. R. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32836162aa · Cited by 42
Tomiki, Y., Suda, S., Tanaka, M., Okuzawa, A., Matsuda, M., Ishibiki, Y., Sakamoto, K., Kamano, T., Tsurumaru, M., & Watanabe, Y. Y. (2004) · PubMed · Cited by 42
The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer
Munir, M. T., Ponce, C., Powell, C. A., Tarafdar, K., Yanagita, T., Choudhury, M., Gollahon, L., & Rahman, S. M. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.05.001 · Cited by 41
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0091 · Cited by 39
Self-citationBlücher, C., Iberl, S., Schwagarus, N., Müller, S., Liebisch, G., Höring, M., Hidrobo, M. S., Ecker, J., Spindler, N., Dietrich, A., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1223 · Cited by 39
Zelenko, Z., Gallagher, E. J., Tobin‐Hess, A., Belardi, V., Rostoker, R., Blank, J., Dina, Y., & LeRoith, D. (2016) · Oncogene · doi:10.1038/onc.2016.305 · Cited by 38
Self-citationMaliniak, M. L., Cheriyan, A. M., Sherman, M. E., Liu, Y., Gogineni, K., Liu, J., He, J., Krishnamurti, U., Miller‐Kleinhenz, J. M., Ashiqueali, R., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01308-4 · Cited by 38
Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link
Asghari, A., & Umetani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144822 · Cited by 38
Low-density lipoprotein receptor mRNA in human breast cancer cells: Influence by PKC modulators
Stranzl, A., Schmidt, H., Winkler, R., & Kostner, G. M. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005754026205 · Cited by 37
Tian, W., Pang, W., Ge, Y., He, X., Wang, D., Li, X., Hou, H., Zhou, D., Feng, S., Chen, Z., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26498 · Cited by 37
Plasma C-Peptide, Mammographic Breast Density, and Risk of Invasive Breast Cancer
Ahern, T. P., Hankinson, S. E., Willett, W. C., Pollak, M., Eliassen, A. H., & Tamimi, R. M. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0375 · Cited by 36
Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2
Sarkar, P. L., Lee, W., Williams, E. D., Lubik, A. A., Stylianou, N., Shokoohmand, A., Lehman, M., Hollier, B. G., Gunter, J. H., & Nelson, C. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00481 · Cited by 36
Chan, J. Y., LaPara, K. S., & Yee, D. (2016) · Oncogene · doi:10.1038/onc.2015.488 · Cited by 35
Chen, H., Cook, L. S., Tang, M.-T. C., Hill, D. A., Wiggins, C. L., & Li, C. I. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0291 · Cited by 35
Zylla, D. M., Gilmore, G., Eklund, J. P., Richter, S. A., & Carlson, A. L. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.12.012 · Cited by 34
Hirayama, T. T., Mizokami, Y., Honda, A., Homma, Y., Ikegami, T., Saito, Y., Miyazaki, T., & Matsuzaki, Y. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00450.x · Cited by 33
Tan, P., Wei, S., Tang, Z., Gao, L., Zhang, C., Nie, P., Yang, L., & Wei, Q. (2016) · Scientific Reports · doi:10.1038/srep24521 · Cited by 32
Cornet, C. L., Walter, B., Sookthai, D., Johnson, T., Kuhn, T. E., Herpel, E., Kaaks, R., & Fortner, R. T. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-1253-6 · Cited by 32
Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women
Liang, X., Margolis, K. L., HENDRYX, M. S., Rohan, T. E., Groessl, E. J., Thomson, C. A., Kroenke, C. H., Simon, M. S., Lane, D. S., Stefanick, M. L., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0761 · Cited by 31
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice
Zelenko, Z., Gallagher, E. J., Antoniou, I. M., Sachdev, D., Nayak, A., Yee, D., & LeRoith, D. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0142 · Cited by 30
Self-citationAdult weight gain accelerates the onset of breast cancer
Azrad, M., Blair, C. K., Rock, C. L., Sedjo, R. L., Wolin, K. Y., & Demark‐Wahnefried, W. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05268-y · Cited by 29
Wang, J., Tan, M., Ge, J., Zhang, P., Zhong, J., Tao, L., Wang, Q., Tong, X., & Qiu, J. (2018) · Cell Proliferation · doi:10.1111/cpr.12452 · Cited by 28
Zwickl, H., Hackner, K., Köfeler, H. C., Krzizek, E.-C., Muqaku, B., Pils, D., Scharnagl, H., Solheim, T. S., Zwickl-Traxler, E., & Pecherstorfer, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01262 · Cited by 27
Starkey, N. J. E., Li, Y., Drenkhahn, S. K., Liu, J., & Lubahn, D. B. (2018) · Endocrinology · doi:10.1210/en.2018-00081 · Cited by 26
Multi-omics Analysis Reveals Adipose–tumor Crosstalk in Patients with Colorectal Cancer
Holowatyj, A. N., Haffa, M., Lin, T., Scherer, D., Gigic, B., Ose, J., Warby, C. A., Himbert, C., Abbenhardt, C., Achaintre, D., et al. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0538 · Cited by 24
Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients
Greenlee, H., Shi, Z., Hibshoosh, H. H., Giri, D. D., Ahmed, A., Williams, S. K., Falcone, D. J., Winston, L. A., Zhou, X. K., Hudis, C. A., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0207 · Cited by 21
Sadeghi, A., Shab‐Bidar, S., Parohan, M., & Djafarian, K. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1595049 · Cited by 21
Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency
Luo, C., Liang, J., Sharabi, K., Hatting, M., Perry, E. A., Tavares, C. D. J., Goyal, L., Srivastava, A., Bilodeau, M., Zhu, A. X., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0106 · Cited by 21
Chamberlin, T., Clack, M., Silvers, C., Kuziel, G. M., Thompson, V., Johnson, H. E., & Arendt, L. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0789 · Cited by 21
Non-small cell lung cancer cell survival crucially depends on functional insulin receptors
Frisch, C. M., Zimmermann, K., Zilleßen, P., Pfeifer, A., Racké, K., & Mayer, P. E. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0581 · Cited by 19
Midlife weight gain is a risk factor for obesity-related cancer
Chadid, S., Singer, M. R., Kreger, B. E., Bradlee, M. L., & Moore, L. L. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0106-x · Cited by 19
Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice
Zhang, I. Y., Zhou, H., Liu, H., Zhang, L., Gao, H., Liu, S., Song, Y., Alizadeh, D., Yin, H. H., Pillai, R. K., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2520 · Cited by 18
OP449 inhibits breast cancer growth without adverse metabolic effects
Shlomai, G., Zelenko, Z., Antoniou, I. M., Stasinopoulos, M., Tobin‐Hess, A., Vitek, M. P., LeRoith, D., & Gallagher, E. J. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0077 · Cited by 17
Self-citationWu, B., Teng, L., He, D., Yu, D., & Jiang, F. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1529147 · Cited by 17
Krogh, H. W., Svendsen, K., Igland, J., Mundal, L. J., Holven, K. B., Bogsrud, M. P., Leren, T. P., & Retterstøl, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-55682-x · Cited by 15
Shen, Z., Jiao, K., Teng, M., & Li, Z. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1715965 · Cited by 15
The Impact of Obesity on Tumor Glucose Uptake in Breast and Lung Cancer
Leitner, B. P., & Perry, R. J. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa007 · Cited by 13
Effect of dietary cholesterol intake on the risk of esophageal cancer: a meta-analysis
Jin, Y., Yang, T., Li, D., & Ding, W. (2019) · Journal of International Medical Research · doi:10.1177/0300060519865632 · Cited by 12
Vaysse, C., Lømo, J., Garred, Ø., Fjeldheim, F., Lofterød, T., Schlichting, E., McTiernan, A., Frydenberg, H., Husøy, A., Lundgren, S., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0030-x · Cited by 5
Cited by
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 302
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tomuleasa, C., Tigu, A.-B., Munteanu, R., Moldovan, C.-S., Kegyes, D., Onaciu, A., Gulei, D., Ghiaur, G., Einsele, H., & Croce, C. M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01899-w · Cited by 260
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Ibrahim, S. S., Ibrahim, R. S., Arabi, B., Brockmueller, A., Shakibaei, M., & Büsselberg, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10192-9 · Cited by 56
Jang, A.-R., Jung, D.-H., Lee, T.-S., Kim, J.-K., Lee, Y.-B., Lee, J.-Y., Kim, S.-Y., Yoo, Y.-C., Ahn, J.-H., Hong, E.-H., et al. (2024) · Nutrition · doi:10.1016/j.nut.2024.112565 · Cited by 20
Lee, S.-Y., Lai, H., Chua, Y. J., Wang, M. X., & Lee, G.-H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.880749 · Cited by 14
Metadata
- Authors
- Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-02
- Volume
- 10
- Pages
- 615375-615375
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3127801036
- Cited by
- 256
- References
- 324
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.